Skip to content
healthcare.dev
Get a free key

IMJUDO

NDC 0310-4535, tremelimumab, injection, solution, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-4535
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761289
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-4535 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TREMELIMUMAB300 mg/15mL

Pharmacologic classes

CTLA-4-directed Antibody Interactions [MoA]; CTLA-4-directed Blocking Antibody [EPC]; Increased T Lymphocyte Activation [PE]

Package NDCNDC-11Package
0310-4535-30003104535301 VIAL in 1 CARTON (0310-4535-30) / 15 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6690679c-be2f-4588-a2e4-89fff74dd6be

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0310-4535

Use it

Look up 0310-4535 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-4535 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-4535. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.